VISTAGEN THERAPEUTICS, INC. Common Stock, Capital Shares Reserved for Future Issuance
VISTAGEN THERAPEUTICS, INC. (VTGN) had Common Stock, Capital Shares Reserved for Future Issuance of 67.73 million shares as of 2026-03-31, per its 10-K filed 2026-06-15.
Financial Statements › Notes
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-06-15
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 67.73M shares.
- 2025-03-31: Common Stock, Capital Shares Reserved for Future Issuance 78.10M shares.
- 2024-03-31: Common Stock, Capital Shares Reserved for Future Issuance 75.10M shares.
- 2023-03-31: Common Stock, Capital Shares Reserved for Future Issuance 1.81M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-03-31 | 67.73M shares 10-K · filed 2026-06-15 | |
| 2025-03-31 | 78.10M shares 10-K · filed 2026-06-15 | |
| 2024-03-31 | 75.10M shares 10-K · filed 2025-06-17 | |
| 2023-03-31 | 1.81M shares 10-K · filed 2024-06-11 | |
| 2022-03-31 | 62.64M shares 10-K · filed 2022-06-23 | |
| 2021-03-31 | 53.43M shares 10-K · filed 2021-06-29 | |
| 2018-03-31 | 30.78M shares 10-K · filed 2018-06-26 | |
| 2017-03-31 | 1.21B shares 10-K · filed 2017-06-29 | |
| 2016-03-31 | 10.43M shares 10-K · filed 2016-06-24 | |
| 2014-03-31 | 4.32M shares 10-K · filed 2015-06-29 | |
| 2013-03-31 | 146.07M shares 10-K · filed 2014-06-25 | 68.69M shares 10-K · filed 2013-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |